Esther van den Boom - 06 Sep 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role: Chief Financial Officer
Signature: /s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol: TYRA
Transactions as of: 06 Sep 2022
Net transactions value: +$15,346
Form type: 4
Filing time: 08 Sep 2022, 17:53:47 UTC
Previous filing: 04 Nov 2021
Next filing: 19 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TYRA	Common Stock	Award	$15,346	+1,800	+1.5%	$8.53	120,445	15 Mar 2022	Direct	F1
holding	TYRA	Common Stock						118,645	06 Sep 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TYRA	Stock Option (Right to Buy)	Award	$0	+105,000		$0.000000	105,000	06 Sep 2022	Common Stock	105,000	$7.14	Direct	F3
transaction	TYRA	Stock Option (Right to Buy)	Award	$0	+89,054		$0.000000	89,054	06 Sep 2022	Common Stock	89,054	$7.14	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
F3	1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F4	1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.